Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China
· Delayed Price · Currency is CNY 6.93
-0.03 (-0.43%)
Apr 30, 2026, 11:05 AM CST
Guangdong VTR Bio-Tech Revenue
In the year 2025, Guangdong VTR Bio-Tech had annual revenue of 832.26M CNY with 0.73% growth. Guangdong VTR Bio-Tech had revenue of 219.14M in the quarter ending December 31, 2025, with 0.64% growth.
Revenue
832.26M
Revenue Growth
+0.73%
P/S Ratio
4.02
Revenue / Employee
755.22K
Employees
1,102
Market Cap
3.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 832.26M | 6.05M | 0.73% |
| Dec 31, 2024 | 826.20M | 30.18M | 3.79% |
| Dec 31, 2023 | 796.02M | -377.98M | -32.20% |
| Jan 1, 2023 | 1.17B | -718.15M | -37.95% |
| Jan 1, 2022 | 1.89B | -22.60M | -1.18% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Model Organisms Center | 421.02M |
| Landfar Bio-medicine | 415.94M |
| Jiangsu Sihuan Bioengineering | 381.71M |
| Shenzhen Bioeasy Biotechnology | 271.53M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Shandong Sito Bio-technology | 954.76M |
| Beijing Kawin Technology Share-Holding | 1.30B |
| Novoprotein Scientific | 146.44M |